A Perimenopausal Woman With a Small, ER/HER2-Positive, Node-Negative Breast Cancer

被引：0
|
作者：
Brooks, Gabriel [6 ]
Borges, Virginia
Singh, Meenakshi [5 ]
Rabinovitch, Rachel [4 ]
Finlayson, Christina [3 ]
Elias, Anthony [1 ,2 ]
机构：
[1] Univ Colorado, Ctr Canc, Div Med Oncol, Sch Med, Aurora, CO 80045 USA
[2] Univ Colorado, Breast Canc Res Program, Sch Med, Aurora, CO 80045 USA
[3] Univ Colorado, Sch Med, Dept Surg, Aurora, CO 80045 USA
[4] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO 80045 USA
[5] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80045 USA
[6] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA
来源：
ONCOLOGY-NEW YORK | 2008年 / 22卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1270 / 1276
页数：7
相关论文
共 50 条
  • [1] Trastuzumab and Chemotherapy May Be Appropriate for Small, Node-Negative, HER2-Positive Breast Cancer
    Morris, Patrick G.
    McArthur, Heather L.
    ONCOLOGIST, 2012, 17 (10): : E33 - E33
  • [2] Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
    Tolaney, Sara M.
    Barry, William T.
    Dang, Chau T.
    Yardley, Denise A.
    Moy, Beverly
    Marcom, P. Kelly
    Albain, Kathy S.
    Rugo, Hope S.
    Ellis, Matthew
    Shapira, Iuliana
    Wolff, Antonio C.
    Carey, Lisa A.
    Overmoyer, Beth A.
    Partridge, Ann H.
    Guo, Hao
    Hudis, Clifford A.
    Krop, Ian E.
    Burstein, Harold J.
    Winer, Eric P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (02): : 134 - 141
  • [3] Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
    Cochereau, D.
    Cottu, P.
    ONCOLOGIE, 2015, 17 (04) : 194 - 196
  • [4] Optimal adjuvant therapy for small node-negative HER2-positive breast cancer in clinical practice
    Osako, T.
    Nishimura, R.
    Nishiyama, Y.
    Okumura, Y.
    Fujisue, M.
    Arima, N.
    BREAST, 2017, 32 : S25 - S25
  • [5] Trastuzumab and Chemotherapy May Be Appropriate for Small, Node-Negative, HER2-Positive Breast Cancer In Reply
    Connolly, Roisin M.
    Bardia, Aditya
    ONCOLOGIST, 2012, 17 (10): : E34 - E34
  • [6] Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer
    McArthur, Heather L.
    Mahoney, Kathleen M.
    Morris, Patrick G.
    Patil, Sujata
    Jacks, Lindsay M.
    Howard, Jane
    Norton, Larry
    Hudis, Clifford A.
    CANCER, 2011, 117 (24) : 5461 - 5468
  • [7] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    van Ramshorst, Mette S.
    van der Heiden-van der Loo, Margriet
    Dackus, Gwen M. H. E.
    Linn, Sabine C.
    Sonke, Gabe S.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 361 - 371
  • [8] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    Mette S. van Ramshorst
    Margriet van der Heiden-van der Loo
    Gwen M. H. E. Dackus
    Sabine C. Linn
    Gabe S. Sonke
    Breast Cancer Research and Treatment, 2016, 158 : 361 - 371
  • [9] The Effect of Adjuvant Treatment in Small Node-negative HER2-positive Breast Cancer: Which Subgroup Will Benefit?
    Lin, Haiping
    Zheng, Hongjuan
    Ge, Chenyang
    Wang, Qinghua
    Tang, Wanfen
    Zhang, Xia
    Zhou, Shishi
    Jin, Xiayun
    Xu, Xifeng
    Du, Jinlin
    Fu, Jianfei
    CLINICAL BREAST CANCER, 2020, 20 (06) : 503 - 510
  • [10] Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    Mette S. van Ramshorst
    Margriet van der Heiden-van der Loo
    Gwen M. H. E. Dackus
    Sabine C. Linn
    Gabe S. Sonke
    Breast Cancer Research and Treatment, 2016, 159 : 393 - 393
12345